Who Exports Amikacin from India — 327 Suppliers Behind a $21.1M Market
India's amikacin export market is supplied by 327 active exporters who collectively shipped $21.1M across 1,657 shipments. AVET LIFESCIENCES PRIVATE LIMITED leads with a 15.2% market share, followed by LINCOLN PHARMACEUTICALS LTD and AJANTA PHARMA LIMITED. The top 5 suppliers together control 47.7% of total export value, reflecting a moderately competitive market structure.
Top Amikacin Exporters from India — Ranked by Export Value
AVET LIFESCIENCES PRIVATE LIMITED is the leading amikacin exporter from India, holding a 15.2% share of the $21.1M market across 1,657 shipments from 327 exporters. The top 5 suppliers — AVET LIFESCIENCES PRIVATE LIMITED, LINCOLN PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED, EMCURE PHARMACEUTICALS LIMITED, LYKA LABS LIMITED — collectively control 47.7% of total export value, indicating a competitive market. Individual shares are: AVET LIFESCIENCES PRIVATE LIMITED (15.2%), LINCOLN PHARMACEUTICALS LTD (12.2%), AJANTA PHARMA LIMITED (7.9%), EMCURE PHARMACEUTICALS LIMITED (7.1%), LYKA LABS LIMITED (5.3%).
Top Amikacin Exporters from India
Ranked by export value · 327 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | AVET LIFESCIENCES PRIVATE LIMITED MEDICINES:AMIKACIN SULFATE INJ USP 1G/4MMEDICINES:AMIKACIN SULFAT INJ US 500MG/2MEDICINES - AMIKACIN SULFATE INJ 1G/4ML | $3.2M | 1 | 15.2% |
| 2 | LINCOLN PHARMACEUTICALS LTD AMIKACIN SULFATE INJECTION USP (EMICA-50AMIKACIN SULFATE INJECTION USP (EMICA-10ELEKACIN USP 500MG | $2.6M | 3 | 12.2% |
| 3 | AJANTA PHARMA LIMITED ELEKACIN USP 500MGAMCLIN 500 | $1.7M | 1 | 7.9% |
| 4 | EMCURE PHARMACEUTICALS LIMITED AMIKACIN SULFATE INJ 500MG/2ML MA CA SNMEDICINES AMIKACIN SULFATE INJ 500MG/2MLTILLO UK SN | $1.5M | 3 | 7.1% |
| 5 | LYKA LABS LIMITED ELEKACIN USP 500MGAMCLIN 500AMIKACIN SULFATE INJECTION USP 500MG/2M | $1.1M | 2 | 5.3% |
| 6 | BRAWN LABORATORIES LIMITED AMIKACIN SULFATE INJECTION USP (EMICA-50AMIKACIN SULFATE INJECTION USP (EMICA-10ELEKACIN USP 500MG | $1.1M | 4 | 5.1% |
| 7 | SCOTT EDIL PHARMACIA LIMITED ELEKACIN USP 500MGAMCLIN 500AMIKOZIT (STERILE AMIKACIN SULPHATE INJE | $875.1K | 15 | 4.1% |
| 8 | LABORATE PHARMACEUTICALS INDIA LTD AMIKOZIT (STERILE AMIKACIN SULPHATE INJEAMIKACIN SULFATE INJECTION USP 500MG/2MAMCLIN INJECTION 500MG (AMIKACIN SULFATE | $701.0K | 7 | 3.3% |
| 9 | AVET LIFESCIENCES LIMITED MEDICINES:AMIKACIN SULFATE INJ USP 1G/4MMEDICINES:AMIKACIN SULFAT INJ US 500MG/2MEDICINES - AMIKACIN SULFATE INJ 1G/4ML | $477.8K | 1 | 2.3% |
| 10 | EMCURE PHARMACEUTICALS LTD AMIKACIN SULFATE INJ 500MG/2ML MA CA SNMEDICINES AMIKACIN SULFATE INJ 500MG/2MLTILLO UK SN | $334.4K | 1 | 1.6% |
| 11 | SWISS PARENTERALS LIMITED ELEKACIN USP 500MGAMCLIN 500AMIKACIN SULPHATE INJ,USP 500MG/2ML(CINM | $318.5K | 5 | 1.5% |
| 12 | KWALITY PHARMACEUTICALS LIMITED AMIKOZIT (STERILE AMIKACIN SULPHATE INJEAMIKACIN-500 INJ. | $269.2K | 5 | 1.3% |
| 13 | MEDCELL PHARMA AMIKOZIT (STERILE AMIKACIN SULPHATE INJEAMIKACIN SULFATE INJECTION USP 500MG/2MAMCLIN INJECTION 500MG (AMIKACIN SULFATE | $267.9K | 3 | 1.3% |
| 14 | PREGEN EXPORTS (INDIA) ELEKACIN USP 500MGAMCLIN 500AMIKOZIT (STERILE AMIKACIN SULPHATE INJE | $243.1K | 2 | 1.2% |
| 15 | CHANDRA BHAGAT PHARMA PVT LTD AMIKOZIT (STERILE AMIKACIN SULPHATE INJEAMIKACIN-500 INJ. | $224.1K | 1 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Amikacin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Emcure Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | FDA-approved with WHO and EU GMP certifications; received FDA warning letter in |
| Ajanta Pharma Limited | Approved | Yes | Yes | 27 | FDA-approved with WHO and EU GMP certifications; holds 27 ANDAs; no FDA warning |
| Avet Lifesciences Private Limited | Approved | Unknown | Unknown | Multiple | FDA-approved; multiple ANDAs; WHO and EU GMP status not found; no FDA warning le |
| Lincoln Pharmaceuticals Ltd | Not Listed | Yes | Yes | Not Applicable | WHO and EU GMP certified; not listed with FDA; no FDA warning letters. |
| Lyka Labs Limited | Not Listed | Yes | Yes | Not Applicable | WHO and EU GMP certified; not listed with FDA; no FDA warning letters. |
| Brawn Laboratories Limited | Not Listed | Yes | Yes | Not Applicable | WHO and EU GMP certified; not listed with FDA; no FDA warning letters. |
| Scott Edil Pharmacia Limited | Not Listed | Yes | Yes | Not Applicable | WHO and EU GMP certified; not listed with FDA; no FDA warning letters. |
| Laborate Pharmaceuticals India Ltd | Not Listed | Yes | Yes | Not Applicable | WHO and EU GMP certified; not listed with FDA; no FDA warning letters. |
| Kwality Pharmaceuticals Limited | Not Listed | Yes | Yes | Not Applicable | WHO and EU GMP certified; not listed with FDA; no FDA warning letters. |
TransData Nexus reviewed the regulatory standing of 9 leading Amikacin exporters from India. 3 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Amikacin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), including antibiotics like Amikacin. The establishment of Hyderabad Pharma City aims to further enhance this ecosystem by providing integrated facilities for pharmaceutical manufacturing, research, and development.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region houses several leading pharmaceutical companies that specialize in producing finished dosage forms, including injectables and oral formulations. The presence of a robust infrastructure and a skilled workforce makes this cluster pivotal in the formulation of antibiotics such as Amikacin.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a significant export gateway for pharmaceutical products. With its proximity to major ports and well-established logistics networks, this cluster facilitates the efficient export of antibiotics like Amikacin to global markets. The region's pharmaceutical companies benefit from advanced manufacturing facilities and regulatory compliance, ensuring the production of high-quality products for international distribution.
4Baddi-Nalagarh — Tax Incentive Zone
Located in Himachal Pradesh, the Baddi-Nalagarh region has emerged as a prominent pharmaceutical manufacturing hub, largely due to favorable tax incentives and supportive government policies. This cluster attracts numerous pharmaceutical companies specializing in the production of various drugs, including antibiotics. The cost advantages and conducive business environment make it an attractive location for manufacturing Amikacin.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements to maintain product integrity.
- Assess Logistics Infrastructure: Consider the logistical capabilities of each region, especially export facilities, to optimize supply chain efficiency.
- Monitor Market Dynamics: Stay informed about regional policies, tax incentives, and market trends that may impact sourcing decisions.
By strategically analyzing India's pharmaceutical clusters, companies can make informed decisions regarding the sourcing and manufacturing of Amikacin, ensuring a resilient and efficient supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Amikacin exporters from India
Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals launches IPO on NSE and BSE
Emcure Pharmaceuticals Limited, a leading Indian pharmaceutical company, launched its initial public offering (IPO) and listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in July 2024. - IMPACT: The IPO is expected to provide Emcure with additional capital to expand its operations, potentially enhancing its Amikacin production and export capabilities.
Impact: The IPO is expected to provide Emcure with additional capital to expand its operations, potentially enhancing its Amikacin production and export capabilities.
Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals to acquire remaining stake in Zuventus Healthcare
Emcure Pharmaceuticals announced its decision to purchase the outstanding minority interest in Zuventus Healthcare, its subsidiary, for ₹724.9 crore. This acquisition aims to simplify Emcure's corporate structure and strengthen its position in the domestic pharmaceutical market. - IMPACT: The full acquisition of Zuventus Healthcare may lead to operational synergies, potentially boosting Amikacin production and exports.
Impact: The full acquisition of Zuventus Healthcare may lead to operational synergies, potentially boosting Amikacin production and exports.
Eris Lifesciences and Natco Pharma Limited — Eris Lifesciences partners with Natco Pharma to commercialize semaglutide in India
Eris Lifesciences entered into a strategic partnership with Natco Pharma Limited to commercialize semaglutide in India. Natco received approval to manufacture generic semaglutide, with a planned launch in March 2026. This collaboration combines Eris' strong commercial presence in diabetology with Natco's manufacturing and regulatory expertise. - IMPACT: While this collaboration focuses on semaglutide, it reflects a trend of strategic partnerships in the pharmaceutical industry, which could influence future collaborations related to Amikacin production and export.
Impact: While this collaboration focuses on semaglutide, it reflects a trend of strategic partnerships in the pharmaceutical industry, which could influence future collaborations related to Amikacin production and export.
Common Questions — Amikacin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which amikacin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, AVET LIFESCIENCES PRIVATE LIMITED leads with 47 recorded shipments worth $3.2M. LINCOLN PHARMACEUTICALS LTD (9 shipments) and AJANTA PHARMA LIMITED (28 shipments) are also established high-volume exporters.
Q How many amikacin manufacturers are there in India?
India has 327 active amikacin exporters with a combined export market of $21.1M across 1,657 shipments to 104 countries. The top 5 suppliers hold 47.7% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for amikacin from India?
Average FOB unit price: $5.67 per unit, ranging from $0.01 to $708.12. Average shipment value: $12.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 327 verified Indian exporters of Amikacin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,657 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 104 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,657 Verified Shipments
327 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists